Drug-Drug Interaction Assessment for Therapeutic Proteins Guidance for Industry
Drug-Drug Interaction Assessment for Therapeutic Proteins Guidance for Industry guidance is to help sponsors of investigational new drug (IND) applications and applicants of biologic…
Read more →Chronic Rhinosinusitis with Nasal Polyps: Developing Drugs for Treatment
Chronic Rhinosinusitis With Nasal Polyps: Developing Drugs for Treatment. The purpose of this guidance is to assist sponsors in the development of drugs or…
Read more →Waivers Exceptions and Exemptions from the Requirements of Section 582 of the Federal Food Drug and Cosmetic Act
Waivers, Exceptions, and Exemptions from the Requirements of Section 582 of the Federal Food, Drug, and Cosmetic Act. This guidance describes the process an…
Read more →Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act
Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act guidance is intended to assist supply chain stakeholders, particularly…
Read more →Electronic Submission Template for Medical Device 510(k) Submissions
Electronic Submission Template for Medical Device 510(k) Submissions guidance provides the standards for the submission of premarket notification (510(k)) submissions by electronic format, a…
Read more →Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol
Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol. This guidance is intended to alert pharmaceutical manufacturers and pharmacists in State-licensed pharmacies…
Read more →